Mark Leick

38PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Oct 19, 2026
Prophylactic IFN-γ blockade drives axi-cel expansion without preventing refractory toxicities: caution against pre-emptive use.

|Sep 18, 2026
Gene regulatory elements determine efficacy of BCMA-targeted CAR-T cell products.

|Sep 02, 2026
Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T.

|Jul 24, 2026
Genomic correlates of clinical CAR T cell activity.

|Feb 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma.

Eli P Darnell, Kathleen M E Gallagher, Justyna Kanska

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

Pageof 7

Frequent Collaborators

30 joint publications

Marcela V Maus

12 joint publications

Filippo Birocchi

11 joint publications

Giulia Escobar

8 joint publications

Alexander Armstrong